Fundraising FoxZejula
1 known investors
Find your way into Zejula
Sign up to see every warm intro you have to Zejula
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zejula team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ZEJULA is a prescription oral medicine (niraparib) used as maintenance treatment in adults with advanced ovarian, fallopian tube, or primary peritoneal cancer that has responded to platinum-based chemotherapy, including cancers with abnormal BRCA genes or homologous recombination deficiency. It is a pharmaceutical product in the oncology category.
Investors · 1
Frequently asked questions
- What does Zejula do?
- ZEJULA is a prescription oral medicine (niraparib) used as maintenance treatment in adults with advanced ovarian, fallopian tube, or primary peritoneal cancer that has responded to platinum-based chemotherapy, including cancers with abnormal BRCA genes or homologous recombination deficiency. It is a pharmaceutical product in the oncology category.
- Who are Zejula's investors?
- Zejula's investors include DRI Healthcare.